Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed early-phase tilt small index

Diabetic Polyneuropathy: early-phase trial registry

A small indexed set (2 trials) with no open enrollment listed right now.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · none currently recruiting · #7,188 of 28,707 conditions by registered trial count

Diabetic Polyneuropathy: 2 US clinical trials tracked, none currently recruiting.

Diabetic Polyneuropathy is the subject of 2 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Sangamo Therapeutics, running 2 of these trials.

Enrollment posture brief

Registry condition diabetic-polyneuropathy

OPEN 0 | RECR 0% | LATE 0 | EARLY 2 | RANK #7188 | SPON 2

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Diabetic Polyneuropathy (thi…0%
Open-enrollment share among volume-matched conditions near Diabetic Polyneuropathy

Diabetic Polyneuropathy has no open enrollment in this registry pull (2 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Diabetic Polyneuropathy on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Diabetic Polyneuropathy is recruiting below its size-band peers.

    0 of 2 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 22

Phase Distribution

PhaseTrial count
Phase 2 2

Top Sponsors

Named interventions

Most-linked intervention names on Diabetic Polyneuropathy records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

SB-509 Biological
1 trials
SB-509 Drug
1 trials
Normal Saline Other
1 trials
Placebo Other
1 trials

US sites by state

Facility locations filed on Diabetic Polyneuropathy trials. A trial with sites in several states counts in each.

Texas 2 trials
Pennsylvania 2 trials
New York 2 trials
Nebraska 2 trials
Kansas 2 trials
Florida 2 trials
California 2 trials
Washington 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Diabetic Polyneuropathy page

2 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • No Diabetic Polyneuropathy trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Sangamo Therapeutics sponsors the most Diabetic Polyneuropathy trials on record, review their full trial history before evaluating a specific study. See Sangamo Therapeutics's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Diabetic Polyneuropathy condition card totals 2 registered trials; most-linked intervention SB-509; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.